Cognitive outcomes after tadalafil treatment in patients with cerebral small vessel disease: ETLAS-2 sub-study

Background: Cerebral small vessel disease (CSVD) is the dominant cause of vascular cognitive impairment and dementia. We aimed to test whether continuous daily treatment with the vasoactive phosphodiesterase 5 inhibitor tadalafil improved cognitive performance in patients with CSVD. Methods: This is...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Joakim Ölmestig, Kristian N. Mortensen, Marie B. Thomas, Birgitte Fagerlund, Trevor W. Robbins, Nadia Naveed, Mette M. Nordling, Hanne Christensen, Helle K. Iversen, Mai B. Poulsen, Hartwig R. Siebner, Christina Kruuse
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-01-01
Serie:	Cerebral Circulation - Cognition and Behavior
Soggetti:	CANTAB MoCA SDMT Trail-making test A and B Digit span Verbal fluency
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2666245025001448
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!